Ástralía - enska - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; iron oxide yellow; sodium starch glycollate; microcrystalline cellulose; povidone - indications: amaryl is indicated as an adjunct to diet, exercise and weight loss to lower the blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus.

Evrópusambandið - enska - EMA (European Medicines Agency)

insmed netherlands b.v. - amikacin sulfate - respiratory tract infections - antibacterials for systemic use, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.

Ástralía - enska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pct international pty ltd - rosemary oil - unknown - rosemary oil oil-plant extract active 0.0 - active constituent

Írland - enska - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - cloxacillin benzathine - intramammary suspension - 500 mg/syringe - cloxacillin - cattle - antibacterial

Írland - enska - HPRA (Health Products Regulatory Authority)

univet limited - cefalexin monohydrate; kanamycin monosulphate - intramammary suspension - . - antibacterials for intramammary use - cattle - antibacterial

Írland - enska - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - penethamate hydriodide ; benethamine penicillin ; framycetin sulphate - intramammary suspension - 100, 280, 100 mg/syringe - penethamate hydroiodide, combinations with other antibacterials - cattle - antibacterial

Bandaríkin - enska - NLM (National Library of Medicine)

concordia pharmaceuticals inc. - sodium polystyrene sulfonate (unii: 1699g8679z) (polystyrene sulfonic acid - unii:70ko0r01ry) - sodium cation 4.1 meq in 1 g

Bandaríkin - enska - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 1 mg - amaryl is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see clinical studies (14.1)] . limitations of use amaryl should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings. amaryl is contraindicated in patients with a history of a hypersensitivity reaction to: - glimepiride or any of the product's ingredients [see warnings and precautions (5.2)]. - sulfonamide derivatives: patients who have developed an allergic reaction to sulfonamide derivatives may develop an allergic reaction to amaryl. do not use amaryl in patients who have a history of an allergic reaction to sulfonamide derivatives. risk summary available data from a small number of published studies and postmarketing experience with amaryl use in pregnancy over decades have not identified any drug associated risks for major birth defects, miscarriage, or adverse maternal outcomes. however, sulfonylureas (in

Írland - enska - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - cefoperazone sodium - intramammary suspension - 25 milligram(s)/millilitre - zzz cefoperazon - cattle - antibacterial

Írland - enska - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - amoxicillin trihydrate; potassium clavulanate; prednisolone - intramammary suspension - 200, 50, 10 mg/syringe - antibacterials and corticosteroids - cattle - antibacterial